Silva Pharmaceuticals (DHA:SILVAPHL) Debt-to-Equity : 0.00 (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Silva Pharmaceuticals Debt-to-Equity?

Silva Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Silva Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Silva Pharmaceuticals's Total Stockholders Equity for the quarter that ended in . 20 was BDT0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Silva Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

DHA:SILVAPHL's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.27
* Ranked among companies with meaningful Debt-to-Equity only.

Silva Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for Silva Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silva Pharmaceuticals Debt-to-Equity Chart

Silva Pharmaceuticals Annual Data

Trend

Debt-to-Equity

Silva Pharmaceuticals Semi-Annual Data

Debt-to-Equity

Competitive Comparison of Silva Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Silva Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Silva Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silva Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Silva Pharmaceuticals's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Silva Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Silva Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

Silva Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/
	=	N/A

Silva Pharmaceuticals (DHA:SILVAPHL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Silva Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Silva Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Silva Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silva Pharmaceuticals Ltd (DHA:SILVAPHL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Road No 8/A New, House No 65, Dhanmondi, Dhaka, BGD, 1209

Website

https://www.silvapharma.com

Silva Pharmaceuticals Ltd is engaged in the manufacturing and marketing of pharmaceuticals finished products. The products are manufactured in the categories of Antibiotics, Analgesics, Antidiabetics, Narcotics, Anti pyretic, Antiinflammatory Drugs, Anti ulcerates, Antiemetic, Gastroprokinetic, Antihistamine, Antispasmodic expectorants, Vitamins, and Minerals medicines. The products are sold in the local market of Bangladesh.

Silva Pharmaceuticals Headlines

No Headlines